These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30969217)

  • 1. Accuracy of Three Screening Tools for Prenatal Substance Use.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin KE; Koszowski B; Mark K
    Obstet Gynecol; 2019 May; 133(5):952-961. PubMed ID: 30969217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin K; Koszowski B; Mark K
    BMJ Open; 2018 Feb; 8(2):e020248. PubMed ID: 29455170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy.
    Trocin KE; Oga EA; Mulatya C; Mark KS; Coleman-Cowger VH
    Matern Child Health J; 2022 Jul; 26(7):1488-1495. PubMed ID: 35461364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus.
    Chasnoff IJ; Wells AM; McGourty RF; Bailey LK
    J Perinatol; 2007 Dec; 27(12):744-8. PubMed ID: 17805340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of five self-report screening instruments for substance use in pregnancy.
    Ondersma SJ; Chang G; Blake-Lamb T; Gilstad-Hayden K; Orav J; Beatty JR; Goyert GL; Yonkers KA
    Addiction; 2019 Sep; 114(9):1683-1693. PubMed ID: 31216102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes.
    Chasnoff IJ; McGourty RF; Bailey GW; Hutchins E; Lightfoot SO; Pawson LL; Fahey C; May B; Brodie P; McCulley L; Campbell J
    J Perinatol; 2005 Jun; 25(6):368-74. PubMed ID: 15703775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.
    Trocin KE; Weinstein NI; Oga EA; Mark KS; Coleman-Cowger VH
    J Addict Med; 2020; 14(2):139-144. PubMed ID: 31090554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal Substance Use and Perceptions of Parent and Partner Use Using the 4P's Plus Screener.
    Oga EA; Peters EN; Mark K; Trocin K; Coleman-Cowger VH
    Matern Child Health J; 2019 Feb; 23(2):250-257. PubMed ID: 30523484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of substance use disorders among pregnant women: A comparison of screeners.
    Chang G; Ondersma SJ; Blake-Lamb T; Gilstad-Hayden K; Orav EJ; Yonkers KA
    Drug Alcohol Depend; 2019 Dec; 205():107651. PubMed ID: 31683243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.
    Oga EA; Mark K; Peters EN; Coleman-Cowger VH
    J Addict Med; 2020; 14(5):423-430. PubMed ID: 32032210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS).
    McNeely J; Strauss SM; Saitz R; Cleland CM; Palamar JJ; Rotrosen J; Gourevitch MN
    Am J Med; 2015 Jul; 128(7):784.e9-19. PubMed ID: 25770031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of screening for substance use in pregnant women: commentary on the 4P'S Plus tool.
    Jones HE
    J Perinatol; 2005 Jun; 25(6):365-7. PubMed ID: 15915163
    [No Abstract]   [Full Text] [Related]  

  • 13. The Impact of Social Vulnerability on Substance Use Detection Practices in Pregnancy.
    Lijewski VA; Aldrich H; Straub HL
    Am J Perinatol; 2024 Mar; ():. PubMed ID: 38503303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test).
    Hotham ED; Ali RL; White JM
    Midwifery; 2016 Mar; 34():183-197. PubMed ID: 26673838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR; Northrup TF; Villarreal YR; Berens PD; Blackwell S; Bunag T; Stotts AL
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot Validation of a Brief Screen Tool for Substance Use Detection in Emergency Care.
    Broderick KB; Richmond MK; Fagan J; Long AW
    J Emerg Med; 2015 Sep; 49(3):369-74. PubMed ID: 26054313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of a two-item screen for drug use developed from the alcohol, smoking and substance involvement screening test (ASSIST).
    Tiet QQ; Leyva Y; Moos RH; Smith B
    Drug Alcohol Depend; 2016 Jul; 164():22-27. PubMed ID: 27234660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the alcohol use module from a multidimensional prenatal psychosocial risk screening instrument.
    Harrison PA; Godecker A; Sidebottom AC
    Matern Child Health J; 2012 Dec; 16(9):1791-800. PubMed ID: 22120427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.